Krystal Biotech, Inc. (KRYS) Free cash flow 2016–2025
Krystal Biotech, Inc. (KRYS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$188.9MFY2025 · since FY2016: -$1.3M → $188.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $188.9M | +58.5% |
| FY2024 | $119.2M | +218.5% |
| FY2023 | -$100.6M | +34.5% |
| FY2022 | -$153.5M | -32.1% |
| FY2021 | -$116.3M | -184.1% |
| FY2020 | -$40.9M | -63.1% |
| FY2019 | -$25.1M | -114.8% |
| FY2018 | -$11.7M | -184.9% |
| FY2017 | -$4.1M | -209.2% |
| FY2016 | -$1.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice